HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

N- bis- (3- phenyl- propyl)9- oxo- fluorene- 2,7- diamide

GPI 16552 considered a potentially specific PARG inhibitor
Also Known As:
GPI 16552
Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Zhang, Jie: 3 articles (01/2007 - 07/2003)
2. Li, Jia-He: 2 articles (01/2007 - 07/2003)
3. Massuda, Edmond: 2 articles (01/2007 - 07/2003)
4. Li, Weixing: 2 articles (12/2005 - 07/2003)
5. Xu, Weizhen: 1 article (01/2007)
6. Esposito, Emanuela: 1 article (01/2007)
7. Wang, Zhao-Qi: 1 article (01/2007)
8. Mazzon, Emanuela: 1 article (01/2007)
9. Crisafulli, Concetta: 1 article (01/2007)
10. Malleo, Giuseppe: 1 article (01/2007)

Related Diseases

1. Neoplasm Metastasis (Metastasis)
2. Experimental Melanoma
3. Melanoma (Melanoma, Malignant)
4. Ischemia
5. Colitis

Related Drugs and Biologics

1. N- bis- (3- phenyl- propyl)9- oxo- fluorene- 2,7- diamide
2. 2,4-dinitrofluorobenzene sulfonic acid